375 related articles for article (PubMed ID: 26512631)
1. Microbial signatures in post-infectious irritable bowel syndrome--toward patient stratification for improved diagnostics and treatment.
Jalanka J; Salonen A; Fuentes S; de Vos WM
Gut Microbes; 2015; 6(6):364-9. PubMed ID: 26512631
[TBL] [Abstract][Full Text] [Related]
2. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
Maharshak N; Ringel Y; Katibian D; Lundqvist A; Sartor RB; Carroll IM; Ringel-Kulka T
Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
[TBL] [Abstract][Full Text] [Related]
3. Altered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress.
Sundin J; Rangel I; Fuentes S; Heikamp-de Jong I; Hultgren-Hörnquist E; de Vos WM; Brummer RJ
Aliment Pharmacol Ther; 2015 Feb; 41(4):342-51. PubMed ID: 25521822
[TBL] [Abstract][Full Text] [Related]
4. Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome.
Jalanka-Tuovinen J; Salojärvi J; Salonen A; Immonen O; Garsed K; Kelly FM; Zaitoun A; Palva A; Spiller RC; de Vos WM
Gut; 2014 Nov; 63(11):1737-45. PubMed ID: 24310267
[TBL] [Abstract][Full Text] [Related]
5. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome.
Rajilić-Stojanović M; Biagi E; Heilig HG; Kajander K; Kekkonen RA; Tims S; de Vos WM
Gastroenterology; 2011 Nov; 141(5):1792-801. PubMed ID: 21820992
[TBL] [Abstract][Full Text] [Related]
6. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota.
Jeffery IB; O'Toole PW; Öhman L; Claesson MJ; Deane J; Quigley EM; Simrén M
Gut; 2012 Jul; 61(7):997-1006. PubMed ID: 22180058
[TBL] [Abstract][Full Text] [Related]
7. [Microbiota and irritable bowel syndrome].
Ducrotté P
Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 1():S52-6. PubMed ID: 20889005
[TBL] [Abstract][Full Text] [Related]
8. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
Tap J; Derrien M; Törnblom H; Brazeilles R; Cools-Portier S; Doré J; Störsrud S; Le Nevé B; Öhman L; Simrén M
Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
[TBL] [Abstract][Full Text] [Related]
9. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.
Duboc H; Rainteau D; Rajca S; Humbert L; Farabos D; Maubert M; Grondin V; Jouet P; Bouhassira D; Seksik P; Sokol H; Coffin B; Sabaté JM
Neurogastroenterol Motil; 2012 Jun; 24(6):513-20, e246-7. PubMed ID: 22356587
[TBL] [Abstract][Full Text] [Related]
10. Similar Fecal Microbiota Signatures in Patients With Diarrhea-Predominant Irritable Bowel Syndrome and Patients With Depression.
Liu Y; Zhang L; Wang X; Wang Z; Zhang J; Jiang R; Wang X; Wang K; Liu Z; Xia Z; Xu Z; Nie Y; Lv X; Wu X; Zhu H; Duan L
Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1602-1611.e5. PubMed ID: 27266978
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment.
Parkes GC; Brostoff J; Whelan K; Sanderson JD
Am J Gastroenterol; 2008 Jun; 103(6):1557-67. PubMed ID: 18513268
[TBL] [Abstract][Full Text] [Related]
12. Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome: an evidence-based review.
Schmulson M; Bielsa MV; Carmona-Sánchez R; Hernández A; López-Colombo A; López Vidal Y; Peláez-Luna M; Remes-Troche JM; Tamayo JL; Valdovinos MA
Rev Gastroenterol Mex; 2014; 79(2):96-134. PubMed ID: 24857420
[TBL] [Abstract][Full Text] [Related]
13. Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome.
Carroll IM; Ringel-Kulka T; Siddle JP; Ringel Y
Neurogastroenterol Motil; 2012 Jun; 24(6):521-30, e248. PubMed ID: 22339879
[TBL] [Abstract][Full Text] [Related]
14. Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis.
Liu HN; Wu H; Chen YZ; Chen YJ; Shen XZ; Liu TT
Dig Liver Dis; 2017 Apr; 49(4):331-337. PubMed ID: 28179092
[TBL] [Abstract][Full Text] [Related]
15. Postinfection Irritable Bowel Syndrome: The Links Between Gastroenteritis, Inflammation, the Microbiome, and Functional Disease.
Downs IA; Aroniadis OC; Kelly L; Brandt LJ
J Clin Gastroenterol; 2017; 51(10):869-877. PubMed ID: 28885302
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome.
Carroll IM; Ringel-Kulka T; Keku TO; Chang YH; Packey CD; Sartor RB; Ringel Y
Am J Physiol Gastrointest Liver Physiol; 2011 Nov; 301(5):G799-807. PubMed ID: 21737778
[TBL] [Abstract][Full Text] [Related]
17. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification.
Lyra A; Rinttilä T; Nikkilä J; Krogius-Kurikka L; Kajander K; Malinen E; Mättö J; Mäkelä L; Palva A
World J Gastroenterol; 2009 Dec; 15(47):5936-45. PubMed ID: 20014457
[TBL] [Abstract][Full Text] [Related]
18. Intestinal microbiota and its role in irritable bowel syndrome (IBS).
Ohman L; Simrén M
Curr Gastroenterol Rep; 2013 May; 15(5):323. PubMed ID: 23580243
[TBL] [Abstract][Full Text] [Related]
19. [Irritable Bowel Syndrome, Emotion Regulation, and Gut Microbiota].
Fukudo S
Brain Nerve; 2016 Jun; 68(6):607-15. PubMed ID: 27279158
[TBL] [Abstract][Full Text] [Related]
20. The relationship between faecal-associated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects.
Rangel I; Sundin J; Fuentes S; Repsilber D; de Vos WM; Brummer RJ
Aliment Pharmacol Ther; 2015 Nov; 42(10):1211-21. PubMed ID: 26376728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
